Signal active
Organization
Contact Information
Overview
Founded by world-renowned mycologist Paul Stamets, MycoMedica, PBC is a lifesciences company developing therapeutic drugs derived from fungi to help people live healthier, better lives. Our breakthrough innovation, the Stamets Stack, uses a novel combination of ingredients – not found together in nature – to unlock the potential effectiveness of psilocybin in the prevention and treatment of psychiatric and neurological disorders. More information is available at www.mycomedica.bio.
About
Biotechnology, Life Science, Health Care
2021
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
MycoMedica Life Sciences, PBC headquartered in United States, North America, operates in the Biotechnology, Life Science, Health Care sector. The company focuses on Biotechnology and has secured $2.4B in funding across 36 round(s). With a team of 11-50 employees, MycoMedica Life Sciences, PBC is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - MycoMedica Life Sciences, PBC, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
3
1
0
$68.0M
Details
3
MycoMedica Life Sciences, PBC has raised a total of $68.0M in funding over 3 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2021 | Seed | 8.0M | ||
2022 | Early Stage Venture | 60.0M | ||
2021 | Early Stage Venture |
Investors
MycoMedica Life Sciences, PBC is funded by 15 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
MycoMedica Life Sciences, PBC | - | FUNDING ROUND - MycoMedica Life Sciences, PBC | 60.0M |
Zen Chu | - | FUNDING ROUND - Zen Chu | 60.0M |
MycoMedica Life Sciences, PBC | - | FUNDING ROUND - MycoMedica Life Sciences, PBC | undefined |
Artis Ventures (AV) | - | FUNDING ROUND - Artis Ventures (AV) | undefined |
Recent Activity
There is no recent news or activity for this profile.